Literature DB >> 23362092

New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.

Christoph Wald, Mark W Russo, Julie K Heimbach, Hero K Hussain, Elizabeth A Pomfret, Jordi Bruix.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23362092     DOI： 10.1148/radiol.12121698

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  83 in total

1.  Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma.

Authors:  Jared A White; David T Redden; Mary Kate Bryant; David Dorn; Souheil Saddekni; Ahmed Kamel Abdel Aal; Jessica Zarzour; David Bolus; J Kevin Smith; Stephen Gray; Devin E Eckhoff; Derek A DuBay
Journal:  HPB (Oxford)       Date:  2014-08-26       Impact factor: 3.647

2.  Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observations.

Authors:  Cheng William Hong; Charlie C Park; Adrija Mamidipalli; Jonathan C Hooker; Soudabeh Fazeli Dehkordy; Saya Igarashi; Mohanad Alhumayed; Yuko Kono; Rohit Loomba; Tanya Wolfson; Anthony Gamst; Paul Murphy; Claude B Sirlin
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

Review 3.  LI-RADS 2017: An update.

Authors:  Ania Z Kielar; Victoria Chernyak; Mustafa R Bashir; Richard K Do; Kathryn J Fowler; Donald G Mitchell; Milena Cerny; Khaled M Elsayes; Cynthia Santillan; Aya Kamaya; Yuko Kono; Claude B Sirlin; An Tang
Journal:  J Magn Reson Imaging       Date:  2018-04-06       Impact factor: 4.813

4.  Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up.

Authors:  Mishal Mendiratta-Lala; William Masch; Prasad R Shankar; Holly E Hartman; Matthew S Davenport; Matthew J Schipper; Chris Maurino; Kyle C Cuneo; Theodore S Lawrence; Dawn Owen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-09-10       Impact factor: 7.038

5.  Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy.

Authors:  Sonja Gordic; Jad Bou Ayache; Paul Kennedy; Cecilia Besa; Mathilde Wagner; Octavia Bane; Richard L Ehman; Edward Kim; Bachir Taouli
Journal:  Abdom Radiol (NY)       Date:  2017-06

6.  Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers.

Authors:  Antonio Orlacchio; Fabrizio Chegai; Sebastiano Fabiano; Stefano Merolla; Valentina Funel; Francesca Di Giuliano; Matteo Manuelli; Giuseppe Tisone; Simona Francioso; Mario Angelico; Giampiero Palmieri; Giovanni Simonetti
Journal:  Radiol Med       Date:  2016-04-21       Impact factor: 3.469

Review 7.  Transplant artery thrombosis and outcomes.

Authors:  Mark D Sugi; Hassan Albadawi; Grace Knuttinen; Sailendra G Naidu; Amit K Mathur; Adyr A Moss; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 8.  Role of US LI-RADS in the LI-RADS Algorithm.

Authors:  Shuchi K Rodgers; David T Fetzer; Helena Gabriel; James H Seow; Hailey H Choi; Katherine E Maturen; Ashish P Wasnik; Tara A Morgan; Nirvikar Dahiya; Mary K O'Boyle; Yuko Kono; Claude B Sirlin; Aya Kamaya
Journal:  Radiographics       Date:  2019 May-Jun       Impact factor: 5.333

9.  Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.

Authors:  Riad Salem; Andrew C Gordon; Samdeep Mouli; Ryan Hickey; Joseph Kallini; Ahmed Gabr; Mary F Mulcahy; Talia Baker; Michael Abecassis; Frank H Miller; Vahid Yaghmai; Kent Sato; Kush Desai; Bartley Thornburg; Al B Benson; Alfred Rademaker; Daniel Ganger; Laura Kulik; Robert J Lewandowski
Journal:  Gastroenterology       Date:  2016-08-27       Impact factor: 22.682

10.  Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.

Authors:  Eric C Ehman; Spencer C Behr; Sarah E Umetsu; Nicholas Fidelman; Ben M Yeh; Linda D Ferrell; Thomas A Hope
Journal:  Abdom Radiol (NY)       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.